Skip to main content
. Author manuscript; available in PMC: 2006 Oct 23.
Published in final edited form as: J Int Neuropsychol Soc. 2002 Nov;8(7):943–955. doi: 10.1017/s1355617702870096

Fig. 3.

Fig. 3

The mean scores achieved by the APOE-ε4+ and APOE-ε4− preclinical Alzheimer's disease (AD) participants on key measures from the California Verbal Learning Test (CVLT). The scores are presented as a function of years prior to diagnosis of AD (−2 years vs. −1 year vs. zero years).